Drugs News and Research

RSS

Estrogen–like drugs may help postmenopausal women

Scientists may debate whether weight gain is a side effect of menopause, but the numbers are clear: On average, women may experience a gain of approximately 10-15 pounds in the years surrounding menopause.

19 Apr 2004

Menthol in topical creams relieves Osteoarthritis pain

A new study extends previous research and examines the effects of a topical cream consisting of cetylated fatty acids, along with the addition of menthol, on pain and functional performance in patients with knee osteoarthritis over the course of one week.

19 Apr 2004

New scanning technology allows researchers to look into a kidney

Kidney disease may affect as many as one in twelve people, and causes millions of deaths each year. Currently, the diagnosis of kidney function relies mainly on blood and urine tests, an indirect means of figuring out how well they’re working.

19 Apr 2004

Australian company set to spearhead drug discovery

An Australian company is set to challenge the boundaries of drug discovery in Australia with the unveiling of the nation's top drug discovery facility by Western Australian Minister for State Development, Clive Brown.

19 Apr 2004

Researchers find drug that may suppress genetic mutation using a novel screening approach

Researchers at Massachusetts General Hospital have developed a way of identifying promising new drugs that may get around a major challenge in drug discovery.

18 Apr 2004

Newborn lambs’ central heating system could aid fat busting in humans

The way newborn lambs regulate their temperature in the first few weeks of life using a special deposit of brown fat could give clues for tackling obesity in humans, according to Imperial College London scientists.

18 Apr 2004

Abbott Laboratories attempt to silence AIDS advocates

In a brazen attempt to silence AIDS advocates' ongoing criticism of Abbott Laboratories over its recent 400% price hike on the key AIDS drug Norvir, two prominent gay publications are buckling under pressure from Abbott to refuse to run, or significantly alter, a parody advertisement created by AIDS Healthcare Foundation (AHF) that spoofs the drug giant's media spin on their unprecedented price hike on Norvir.

16 Apr 2004

Delirium in ICU patients a predictor of mortality

Between 60 percent to 80 percent of these patients develop a brain dysfunction known as delirium, which according to a group of physicians at Vanderbilt Medical Center is an independent predictor of mortality.

16 Apr 2004

Scientists will debate E.coli and the adaption by micro-organisms to modern day drugs

This debate will centre around why humans are constantly under attack from infectious diseases such as E.coli despite medical advances in vaccinations and antibiotics, and how micro-organisms that cause disease evolve and adapt quickly to the many barriers that our bodies' anti-infection strategies and our drugs industry throw at them.

16 Apr 2004

New gene presents a potent new target for breast cancer therapy

A gene known to promote longevity in animals has now been discovered to encode a tumor suppressor – a protein that helps prevent cancer, according to a study by a team of scientists from The University of Texas M. D. Anderson Cancer Center. The new gene, which was inactivated in two-thirds of patients studied, presents a potent new target for breast cancer therapy, the researchers say.

16 Apr 2004

How cutting-edge computer techniques can be used to develop drugs

Leading international experts will gather at the University of Bradford's Institute for Pharmaceutical Innovation (IPI) for a conference looking at how cutting-edge computer techniques can be used to develop drugs.

16 Apr 2004

Citrus soda culprit in patient’s medical mystery

It took a team of medical sleuths at Vanderbilt University Medical Center to get to the bottom of what was causing the 35-year-old to have abnormal blood chemistries during a post-transplant check up.

16 Apr 2004

Proteomics techniques to find a possible predictor of response in a chemoprevention trial

Using new technology associated with the study of proteins, or proteomics, scientists at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), and their colleagues have made a step toward predicting which people with familial adenomatous polyposis (FAP), an inherited condition that often leads to colon cancer, will respond to the prevention drug celecoxib.

16 Apr 2004

Sound sleep in infants lessens likelihood of drug abuse in later years

A long-term study has found a significant connection between sleep problems in children’s toddler years and the chance that they’ll use alcohol, cigarettes, and drugs early in their teen years. Young teens whose preschool sleep habits were poor were more than twice as likely to use drugs, tobacco, or alcohol.

16 Apr 2004

Liptor helps Alzheimer’s disease

In a small clinical trial enrolling 63 individuals with Alzheimer’s disease, half of those who received atorvastatin (Lipitor) stabilized or improved after one year of treatment, the trial’s principal investigator D. Larry Sparks, Ph.D., reported today at a professional meeting on Alzheimer therapy.

15 Apr 2004

Hugs and kisses halve risk of heart attack

Having a really close relationship with another person, whether it be friend, lover, or relative, can halve the risk of further heart attacks, suggests research in Heart.

14 Apr 2004

Cancer could be inactivated by RNA library

CANCER RESEARCH UK and the Netherlands Cancer Institute have completed the first stage of a landmark initiative to systematically uncover the function of our genes, the charities announce today.

14 Apr 2004

Cinnamon's role as an insulin substitute in type II diabetes

Cinnamon may be more than a spice – it may have a medical application in preventing and combating diabetes. Cinnamon may help by playing the role of an insulin substitute in type II diabetes, according to cellular and molecular studies at the University of California, Santa Barbara, Iowa State University and the U.S. Department of Agriculture.

14 Apr 2004

Biotech production of Sucanon Diabetes drug commences

Robert Rieveley, President of Biotech Holdings has announced that installation of pharmaceutic processing equipment required for Sucanon production is currently being completed. "Sucanon production is scheduled to begin within the week; our first production run is for 1.2 million Sucanon tablets, sufficient for 20,000 one-month Sucanon treatment packages.

14 Apr 2004

'Medicare-Approved' cards available soon

Beginning in June 2004, the Medicare discount card program will provide America's seniors and disabled Medicare beneficiaries with much-needed discounts and information on their prescription drugs. The purchasing power behind the Medicare population is expected to save beneficiaries an average of 10 to 25 percent off the retail price of most drugs.

14 Apr 2004